Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001. - Chiorean, Elena Gabriela; Damle, Sheela R.; Zhen, David B.; Whittle, Martin; George, Ben; Hochster, Howard; Coveler, Andrew L.; Hendifar, Andrew; Dragovich, Tomislav; Safyan, Rachael A.; King, Gentry T.; Harris, William P.; et al. (Cancers, 2026)